Díez Soraya, Gómez Beatriz L, McEwen Juan G, Restrepo Angela, Hay Rod J, Hamilton Andrew J
St. John's Institute of Dermatology, Guy's Hospital, London, England.
J Clin Microbiol. 2003 Apr;41(4):1536-42. doi: 10.1128/JCM.41.4.1536-1542.2003.
The diagnosis of paracoccidioidomycosis (PCM) has relied on the identification of the host's humoral response by using a variety of immunological methods, such as complement fixation and immunodiffusion. Although these approaches are useful, historically their sensitivity and specificity have often been compromised by the use of complex mixtures of undefined antigens. The use of combinations of purified, well-characterized antigens appears preferable and may yield optimum results. Accordingly an indirect enzyme-linked immunosorbent assay (ELISA) using combinations of the previously described 27-kDa recombinant antigen and the 87-kDa heat shock protein were used for diagnosis and follow-up of patients with PCM. A total of 37 patients classified according to their clinical presentations (7 with the acute or subacute form of the disease, 22 with the chronic form of the disease, and 8 with the chronic unifocal form) were studied. Eighteen of these patients were also evaluated at every follow-up appointment. Forty serum samples from patients with other diseases and 50 serum samples from healthy individuals were also studied. Detection of anti-27-kDa and anti-87-kDa antibodies in sera of patients with PCM by ELISA using a combination of the two purified proteins showed a sensitivity of 92% with a specificity of 88% in comparison with normal human sera and 90% in comparison with the heterologous sera. These results demonstrated a significant increase in sensitivity and specificity compared to results when the antigens were used separately. Thus, the use of combinations of well-defined antigens appears to offer clear advantages over the use of single antigens when diagnosing PCM.
副球孢子菌病(PCM)的诊断一直依赖于通过多种免疫学方法来识别宿主的体液免疫反应,如补体结合试验和免疫扩散法。尽管这些方法很有用,但从历史上看,由于使用了成分不明的复杂抗原混合物,它们的敏感性和特异性常常受到影响。使用纯化的、特征明确的抗原组合似乎更可取,并且可能会产生最佳结果。因此,一种间接酶联免疫吸附测定(ELISA)使用了先前描述的27 kDa重组抗原和87 kDa热休克蛋白的组合,用于PCM患者的诊断和随访。总共研究了37例根据临床表现分类的患者(7例为急性或亚急性疾病形式,22例为慢性疾病形式,8例为慢性单病灶形式)。其中18例患者在每次随访时也进行了评估。还研究了40份来自其他疾病患者的血清样本和50份来自健康个体的血清样本。通过ELISA使用两种纯化蛋白的组合检测PCM患者血清中的抗27 kDa和抗87 kDa抗体,与正常人血清相比,敏感性为92%,特异性为88%,与异种血清相比,特异性为90%。这些结果表明,与单独使用抗原时的结果相比,敏感性和特异性有显著提高。因此,在诊断PCM时,使用定义明确的抗原组合似乎比使用单一抗原具有明显优势。